NDC 16729-367-45 - OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 16729-367
- Requested NDC
- 16729-367-45
- Package NDCs from labels
- 16729-367-10, 16729-367-15, 16729-367-16, 16729-367-17, 16729-367-45, 16729-367-46
- Manufacturer
- Accord Healthcare Inc. | Intas Pharmaceuticals Limited
- Effective date
- 2025-10-29
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| LACTOSE MONOHYDRATE - Accord Healthcare Inc. | Intas Pharmaceuticals Limited | Accord Healthcare Inc. | Intas Pharmaceuticals Limited | 2025-10-29 | HUMAN PRESCRIPTION DRUG LABEL |
| OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE - A-S Medication Solutions | A-S Medication Solutions | 2024-11-13 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 16729-367-10 | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | 30 in 1 BOTTLE | TABLET, FILM COATED | 30 | 7 | |
| 16729-367-15 | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | 90 in 1 BOTTLE | TABLET, FILM COATED | 90 | 7 | |
| 16729-367-16 | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | 500 in 1 BOTTLE | TABLET, FILM COATED | 500 | 7 | |
| 16729-367-17 | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | 1000 in 1 BOTTLE | TABLET, FILM COATED | 1000 | 7 | |
| 16729-367-45 | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | 10 in 1 BLISTER PACK | TABLET, FILM COATED | 10 | 7 | |
| 16729-367-46 | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | 100 in 1 CARTON | TABLET, FILM COATED | 100 | 7 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 16729-367-10 | EA - Each | 16729-367 | aea7451f-249f-4002-a7df-f367e3bb0513 | 1 | 2020-09-14 |
| 16729-367-15 | EA - Each | 16729-367 | 0eff996a-5135-4a4b-a09e-70ccc66334d4 | 1 | 2020-09-14 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Chantecaille Just Skin Tinted Moisturizer Sunscreen Broad Spectrum SPF 15 Tan | TITANIUM DIOXIDE | Chantecaille Beaute Inc | fdf05545-5a21-4238-b0d3-e3fcdfe866ff | 2024-04-24 | Warnings | 15FIX9V2JP |
| Chantecaille Just Skin Tinted Moisturizer Sunscreen Broad Spectrum SPF 15 Topaz | TITANIUM DIOXIDE | Chantecaille Beaute Inc | 2012f671-7889-4e29-b70f-215cbc9dbdc7 | 2024-04-24 | Warnings | 15FIX9V2JP |
| Chantecaille Just Skin Tinted Moisturizer Sunscreen Broad Spectrum SPF 15 Vanilla | TITANIUM DIOXIDE | Chantecaille Beaute Inc | 7133c47d-ed1c-43e9-8cdf-42f7b2f215f5 | 2024-04-24 | Warnings | 15FIX9V2JP |
| Olmesartan Medoxomil | OLMESARTAN MEDOXOMIL | Direct_Rx | 16752f60-655a-f727-e063-6394a90a96b6 | 2024-04-19 | Boxed warning, Warnings, Adverse reactions | 6M97XTV3HD |
| SPF30 Sunscreen Cariposa | TITANIUM DIOXIDE, ZINC OXIDE | Talent Brands Company LLC | 37d696d9-f89d-498e-8fe9-1f08d05d7b61 | 2024-04-18 | Warnings | 15FIX9V2JP |
| Cetaphil Daily Facial Moisturizer with suncreen SPF 50 | OCTINOXATE, OCTISALATE, OCTOCRYLENE, OXYBENZONE, TITANIUM DIOXIDE | Galderma Laboratories, L.P. | 6650d137-e69e-4ec2-8311-3de74bf21315 | 2024-04-17 | Warnings | 15FIX9V2JP |
| Triamterene and Hydrochlorothiazide | TRIAMTERENE AND HYDROCHLOROTHIAZIDE | NuCare Pharmaceuticals,Inc. | cba87d5b-9302-7b2c-e053-2a95a90a7f9d | 2024-04-17 | Boxed warning, Adverse reactions | 0J48LPH2TH |
| SPF 30 Mineral Sunscreen Cariposa | TITANIUM DIOXIDE, ZINC OXIDE | Talent Brands Company LLC | 0bc21573-d302-4d85-8d8f-dca9a48e1f35 | 2024-04-17 | Warnings | 15FIX9V2JP |
| Amlodipine and Olmesartan Medoxomil | AMLODIPINE AND OLMESARTAN MEDOXOMIL | Aurobindo Pharma Limited | b13a8b46-104e-4b75-8f4a-928d2204eff5 | 2024-04-15 | Boxed warning, Warnings, Adverse reactions | 6M97XTV3HD |
| hydrochlorothiazide | HYDROCHLOROTHIAZIDE | A-S Medication Solutions | 39d4dbd3-8f24-4898-a240-e94e06fa229a | 2024-04-11 | Warnings, Adverse reactions | 0J48LPH2TH |
| OLMESARTAN MEDOXOMIL and HYDROCHLOROTHIAZIDE | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | A-S Medication Solutions | 4c0b028d-f0f4-417f-a068-dca24e56113f | 2024-04-10 | Boxed warning, Warnings, Adverse reactions | 403854 0J48LPH2TH 6M97XTV3HD |
| olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide | OLMESARTAN MEDOXOMIL / AMLODIPINE BESYLATE / HYDROCHLOROTHIAZIDE | Bryant Ranch Prepack | a6ebafdc-4301-4d6c-b578-b3212648b13a | 2024-04-08 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH 6M97XTV3HD |
| Triamterene and Hydrochlorothiazide | TRIAMTERENE AND HYDROCHLOROTHIAZIDE | Bryant Ranch Prepack | 5ca13106-f68b-4894-aca2-03e74fff350c | 2024-04-03 | Boxed warning, Adverse reactions | 0J48LPH2TH |
| Triamterene and Hydrochlorothiazide | TRIAMTERENE AND HYDROCHLOROTHIAZIDE | BluePoint Laboratories | b8a55c23-b509-4790-88fa-9dc9bacd4bbe | 2024-03-29 | Warnings, Adverse reactions | 0J48LPH2TH |
| hydrochlorothiazide | HYDROCHLOROTHIAZIDE | Unichem Pharmaceuticals (USA), Inc. | cb7712f3-9a0b-442d-859d-8be5e6e2529a | 2024-03-29 | Warnings, Adverse reactions | 0J48LPH2TH |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | A-S Medication Solutions | 2e4eee3a-fe0c-44aa-8ff1-b14b07a0c5bc | 2024-03-27 | Warnings, Adverse reactions | 0J48LPH2TH |
| RV Illuminance Serum Tint Broad Spectrum 15 | FACE FOUNDATION WITH SPF | REVLON CONSUMER PR Consumer Products Corp | 132aab60-da19-7079-e063-6394a90a1d76 | 2024-03-27 | Warnings | 15FIX9V2JP |
| RV Illuminance Serum Tint Broad Spectrum 15 Amber | FACE FOUNDATION WITH SPF | REVLON CONSUMER PR Consumer Products Corp | 2a0ac71c-e53a-5ff9-e063-6394a90a4807 | 2024-03-27 | Warnings | 15FIX9V2JP |
| EltaMD UV Pure SPF47 | ZINC OXIDE AND TITANIUM DIOXIDE SUNSCREEN | CP Skin Health Group, Inc. | 9afe900b-4186-4189-a871-ad6f26fc26e4 | 2024-03-27 | Warnings | 15FIX9V2JP |
| Amlodipine and Olmesartan Medoxomil | AMLODIPINE AND OLMESARTAN MEDOXOMIL | Amneal Pharmaceuticals NY LLC | 02f9b562-6f7f-4783-bb0d-67c318073e1c | 2024-03-26 | Boxed warning, Warnings, Adverse reactions | 6M97XTV3HD |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.